Le Lézard
Classified in: Science and technology, Business
Subjects: ERN, CCA

Byrna Technologies Inc. Reports Record Third Quarter Fiscal 2020 Results


Revenue Growth Driven by Strong Demand for the Byrna® HD

ANDOVER, Mass., Oct. 9, 2020 /CNW/ -- Byrna Technologies Inc. (OTCQB: BYRN) (CSE: BYRN) today announced results for its fiscal third quarter ended August 31, 2020.

Third Quarter 2020 Compared to Third Quarter 2019:

Nine Months 2020 Compared to Nine Months 2019:

"Byrna Technologies generated a significant increase in sales in our fiscal third quarter, both on a year-over-year and a sequential basis," stated Bryan Ganz, Byrna Technologies' Chief Executive Officer. "The current socio-political climate has created a heightened sense of the need for effective and reliable less-lethal self-defense in both civilians and law enforcement professionals. This, coupled with increased awareness of the unique aspects of our product resulting from favorable, high-profile media coverage, drove rapid order growth for our Byrna® HD less-lethal personal security device." 

Mr. Ganz continued, "As we announced yesterday, we recently commenced production at our new Fort Wayne, IN manufacturing facility.  I am very proud of our team's ability to get this new production capacity up and running nearly a year ahead of plan in order to fulfill our robust backlog and satisfy our customers' orders, as well as capitalize on the extraordinary demand for the Byrna® HD that we expect to continue for the foreseeable future.  With Fort Wayne's 500 unit per day capacity adding to our 600 unit per day production in South Africa, the recent additions to our management team, and investments in corporate infrastructure, we believe Byrna is now very well positioned as a formidable player in the growing less-lethal defense market."

Business Overview
Revenues were $4,198,157 in the third quarter of 2020, representing a year-over-year increase of $3,891,056. This increase was driven by strong growth in orders for the Company's Byrna® HD resulting from enhanced market awareness of the product.

Gross profit was $2,129,534 representing a gross margin of 51% compared to $59,422, or a 19% gross margin in the prior year period. The increase in gross profit was the result of substantially higher revenues, with margin expansion reflecting greater absorption of fixed costs on higher production and sales volumes.

Operating expenses were $2,695,892 in the third quarter of 2020, up from $765,575 in the prior year period.  The increase in operating expenses reflects increased investment in corporate infrastructure to build and support growth in revenues including employee-related expenses, marketing costs, and accounting, auditing, and bank fees.

Financial Position at August 31, 2020:

The Company's cash position at August 31, 2020 was an increase of $10,709,454 from November 30, 2019, primarily due to early warrant exercises and free cash flow (defined as cash flow from operations less purchases of property and equipment) generation during the nine-month period.  Cash flow from operations for the first nine months of fiscal 2020 was $4,784,054 and free cash flow was $3,761,084

Outlook
Mr. Ganz concluded, "Based on our current backlog of orders, the ramp of production at our recently commissioned manufacturing facility in Fort Wayne, and the sustained production rate at our facility in South Africa, we expect revenues for the full fiscal year 2020 to be in the range of $16 ? $18 million. Additionally, we expect our fiscal fourth quarter of 2020 ending November 30th to be our first quarter of positive net income, as we benefit from increasing operating leverage on continued strong sales growth.  Overall, we are optimistic about the Company's prospects for delivering improved profitability and increased cash flow heading into the end of 2020 and entering 2021, as we work to build greater value for our stockholders." 

About Byrna Technologies Inc.
Byrna is a technology company, specializing in the development, manufacture, and sale of innovative less lethal equipment and munitions. For more information on the Company, please visit the corporate website here or the Company's investor relations site here. The Company is the manufacturer of the Byrna®HD personal security device, a state of the art handheld CO2 powered launcher with the look and feel of a handgun, designed to provide a less-lethal alternative to a firearm for the consumer, private security, and law enforcement markets . The Byrna HD is engineered with patented designs and proprietary parts. Unlike pepper spray and stun guns, it has an effective range of up to 60 feet and comes with multiple easily reloadable magazines that can hold multiple .68 caliber hard kinetic rounds or highly chemical irritant and pepper rounds designed to effectively stop an assailant without loss of life or permanent injury.  To purchase Byrna® products visit the Company's e-commerce store.

Forward Looking Information

This news release contains "forward-looking statements" within the meaning of the U.S. and Canadian securities laws. All statements contained in this news release, other than statements of current and historical fact, are forward-looking. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "intends", "anticipates" and "believes" and statements that  certain  actions,  events  or  results  "may", "could",  "would",  "should",  "might," "occur" or "be achieved" or "will be taken." Forward-looking statements include descriptions of currently occurring matters which may continue in the future. Forward-looking statements in this news release include but are not limited to the Company's outlook, including production expectations and continuation of production, projected revenues for the quarter and fiscal year ended November 30, 2020, expectations of positive net income, continued sales growth, profitability, and future greater cash flow.  Forward-looking statements are not, and cannot be, a guarantee of future results or events. Forward-looking statements are based on, among other things, opinions, assumptions, estimates and analyses that, while considered reasonable by the Company at the date the forward-looking information is provided, inherently are subject to significant risks, uncertainties, contingencies and other factors that may cause actual results and events to be materially different from those expressed or implied.

Any number of risk factors could affect our actual results and cause them to differ materially from those expressed or implied by the forward-looking statements in this news release, including, but not limited to: the potential disruption of production or distribution due to the pandemic, civil unrest or otherwise; cancellations of existing or future orders including as a result of fulfillment delay, introduction of competing products, negative publicity, product recalls, or legal developments; changes in the law or personnel turnover that could impact the production, sale of or market for the Company's products or prevent or threaten to prevent the Company's sales, timely financial reporting, or the listing of the Company's securities; extended restriction of the Company's cash resources impacting the availability of sufficient cash to meet operating expenses,  other costs of goods or sales or fund future growth;  increased costs of production or sales and  other events  that could potentially reduce demand for the Company's product or result in order cancellations. The order in which these factors appear should not be construed to indicate their relative importance or priority. We caution that these factors may not be exhaustive, accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results.  Investors should carefully consider these and other relevant factors, including those risk factors in Part I, Item 1A, ("Risk Factors") in our most recent Form 10-K, should understand it is impossible to predict or identify all such factors or risks, should not consider the foregoing list, or the risks identified in our SEC filings, to be a complete discussion of all potential risks or uncertainties., and should not place undue reliance on forward-looking information. The Company assumes no obligation to update or revise any forward-looking information, except as required by applicable law.

BYRNA TECHNOLOGIES INC.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Amounts expressed in US Dollars)

(unaudited)
















For the Three Months Ended



For the Nine Months Ended




August 31,



August 31,




2020



2019



2020



2019


Net revenue


$

4,198,157



$

307,101



$

5,537,141



$

423,977


Cost of goods sold



(2,068,623)




(247,679)




(2,925,580)




(328,512)


Gross profit



2,129,534




59,422




2,611,561




95,465


Operating expenses



2,695,892




765,575




5,663,127




2,597,402


LOSS FROM OPERATIONS



(566,358)




(706,153)




(3,051,566)




(2,501,937)


OTHER (EXPENSE) INCOME

















Accretion of debt discounts



?




(367,457)




(755,401)




(672,517)


Interest expense



?




(109,572)




(233,095)




(256,998)


Loss on extinguishment of debt



?




?




(6,026,654)




?


Warrant inducement expense



?




?




(845,415)




?


Change in fair value of derivative liabilities



?




96,339




?




742,106


LOSS BEFORE INCOME TAXES



(566,358)




(1,086,843)




(10,912,131)




(2,689,346)


Income tax provision



?




?




?




?


NET LOSS



(566,358)




(1,086,843)




(10,912,131)




(2,689,346)



















Foreign exchange translation adjustment for the period



20,156




(52,089)




116,084




(80,208)


COMPREHENSIVE LOSS


$

(546,202)



$

(1,138,932)



$

(10,796,047)



$

(2,769,554)



















Net loss per share ? basic and diluted


$

(0.00)



$

(0.01)



$

(0.09)



$

(0.03)


Weighted-average number of common shares outstanding during the period



134,936,762




104,071,705




120,150,645




103,386,825


 

 

BYRNA TECHNOLOGIES INC.

Condensed Consolidated Balance Sheets

(Amounts expressed in US Dollars)

(unaudited)




August 31,



  November 30,




2020



2019


ASSETS 







CURRENT ASSETS







Cash


$

4,654,408



$

1,081,900


Restricted cash



7,136,946




?


Accounts receivable



617,586




438,255


Inventory, net



3,061,254




959,748


Prepaid expenses and other current assets



2,130,445




377,305


Total current assets



17,600,639




2,857,208











Patent rights, net



827,147




99,002


Deposits for equipment



?




196,921


Right-of-use asset



1,220,725




?


Property and equipment, net



1,797,683




321,288


Goodwill



354,519




?


Restricted cash



92,000




92,000


Other assets



16,718




?


TOTAL ASSETS


$

21,909,431



$

3,566,419


LIABILITIES









CURRENT LIABILITIES









Accounts payable and accrued liabilities


$

2,546,304



$

639,877


Operating lease liabilities, current



227,272




?


Deferred revenue



9,273,401




10,842


Convertible notes payable, net



?




2,758,578


Notes payable



132,593




?


Accrued interest



?




266,143


Total current liabilities



12,179,570




3,675,440











Convertible notes payable, noncurrent



?




1,874,972


Notes payable, non-current



84,578




?


Operating lease liabilities, noncurrent



866,365




?


Total Liabilities


$

13,130,513



$

5,550,412











COMMITMENTS AND CONTINGENCIES (NOTE 12)


















STOCKHOLDERS' EQUITY (DEFICIT)









Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued



?




?


Series A Preferred Stock, 1,500 shares designated, 1,391 and 0 shares issued and outstanding, respectively



1




?


Common stock, $0.001 par value, 300,000,000 shares authorized, 146,408,607 and 104,021,836 shares issued and outstanding, respectively



146,409




104,022


Additional paid-in capital



57,109,090




36,480,520


Shares to be issued



20,000




20,000


Treasury stock, at cost, 0 and 3,699,999 shares, respectively



?




(888,000)


Accumulated deficit



(48,574,254)




(37,662,123)


Accumulated other comprehensive income (loss)



77,672




(38,412)











Total Stockholders' Equity (Deficit)



8,778,918




(1,983,993)











TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)


$

21,909,431



$

3,566,419


 

SOURCE Byrna Technologies Inc.


These press releases may also interest you

at 13:15
Dynamics Communities and Community Summit North America, in collaboration with Microsoft, are introducing the Biz Apps Partner Summit to run July 24-25, 2024, in Bellevue, Washington delivering a 24-hour immersion into FY 25 priorities, opportunities...

at 13:13
E-Textile Market is Segmented by Type (Passive Electronic Textiles, Active Electronic Textiles, Ultra-Electronic Textiles), by Application (Military Uses, Civil Uses, Healthcare Uses). The Global E-Textile Market size is expected to reach USD 5238.3...

at 13:05
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...

at 12:57
Hinkal, a multi-chain privacy layer for confidential decentralized finance (DeFi) transactions, today announced a $1.4 million strategic funding round led by SALT Fund, with participation from Draper Associates, SNZ and Peer VC. Additionally, Tal...

at 12:45
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:39
In an effort to provide the best service possible, enterprise developer Interfuse, has added several important improvements to its Knowledge Base application. Within this update, new pages accessible in the Knowledge Base include Recently Added,...



News published on and distributed by: